Pfizer requests authorization to reinforce the vaccine against COVID-19 in children aged 5 to 11 years
2022-04-27T12:58:55.006Z
According to the pharmaceutical company, studies with minors in this age range showed a strong immune response. The request was made to the FDA in the US and Pfizer said they will also apply for authorization in Canada, the UK and Europe.